Generics increase competition: study
The study by an MIT professor and Analysis Group researchers reportedly confirmed that the increase in generics had not reduced incentives to challenge brand name patents.
Court to allow Sanofi and Regeneron to market Praluent during appeal; Xarelto is effective in treating artery disease; VP advocates for right-to-try laws
The bill, if enacted, would publicly share information about industry payments to physician assistants and nurse practitioners.
Last week President Trump told drugmakers that 'the pricing has been astronomical.'